PEMANFAATAN TES CEPAT MOLEKULER (TCM) GENEXPERT SEBAGAI ALAT DIAGNOSTIK TB PARU DI RSUD WANGAYA KOTA DENPASAR

  • Novianti Novianti Badan Litbang Kemeterian Kesehatan
  • Oster Suriani Simarmata
  • Dina Bisara Lolong
Keywords: GeneXpert, Rapid Diagnosis of Tuberculosis, Pulmonary TBC

Abstract

ABSTRACT

Tuberculosis remains a major public health problem, with an estimated 9 million TB incidence cases, 300,000 of which are drug resistant TB cases and resulted in 1.5 million deaths worldwide in 2013. However, only 58% of new cases, TB cases were confirmed bacteriologically using WHO recommended test including the Xpert® MTB/RIF Rapid Diagnosis. The use of GeneXpert in Indonesia has existed since 2014 and has never been evaluated in its utilization, including in the city of Denpasar, namely in Wangaya Hospital as one of the recipients of the GeneXpert pulmonary TB diagnostic aid. The results of this study showed that the results of GeneXpert examination were much higher in the percentage of Positive TB Case Findings compared to microscopic examination so that there is an increase in the number of positive TB cases by 14.3%. The GeneXpert examination succeeded in giving positive results compared to the microscopic results showing negative results, which were sensitive Rifampicin (14.6%) and resistant Rifampicin (2.4%). However, the utilization of TB suspect examination with GeneXpert has not been maximized in increasing the number of TB patients suspected of having TB, in fact, the percentage of positive TB case finding compared to TB suspicion is increasing.

Keywords:GeneXpert, rapid diagnosis of tuberculosis, pulmonary tuberculosis

 

ABSTRAK

Tuberkulosis (TB) tetap menjadi masalah kesehatan masyarakat yang utama, diperkirakan telah terjadi 9 juta kasus insiden TB, 300.000 di antaranya adalah kasus TB multidrug resistant (TB MDR) dan mengakibatkan 1,5 juta kematian di seluruh dunia pada tahun 2013. Namun, baru 58% dari kasus baru, kasus TB dikonfirmasi secara bakteriologis menggunakan tes yang direkomendasikan oleh WHO termasuk Tes Cepat Molekuler (TCM) GeneXpert® MTB/RIF (Xpert). Pemanfaatan TCM GeneXpert di Indonesia ada sejak 2014 dan belum pernah dilakukan evaluasi dalam pemanfaatannya termasuk di Kota Denpasar yaitu di RSUD Wangaya sebagai salah satu penerima bantuan alat diagnostik TB Paru TCM GeneXpert. Hasil studi menunjukkan bahwa hasil pemeriksaan dengan TCM GeneXpert jauh lebih tinggi persentase penemuan kasus positif TBC dibanding dengan pemeriksaan mikroskopis sehingga terdapat peningkatan jumlah kasus positif TBC sebesar 14,3% di RSUD Wangaya pada tahun 2018.  Pemeriksaan TCM GeneXpert berhasil memberikan hasil yang positif di saat hasil pemeriksaan mikroskopis menunjukkan hasil negatif yaitu Rifampisin sensitif (14,6%) dan Rifampisin resisten (2,4%). Pemanfaatan pemeriksaan terduga TB dengan TCM GeneXpert belum maksimal dalam meningkatkan jumlah pemeriksaan pasien terduga TB Paru, walaupun persentase penemuan kasus positif TB dibanding terduga TB meningkat.

Kata kunci: Tes cepat molekuler, geneXpert, tuberkulosis paru

References

Banada, P. P. et al. (2016) ‘A novel sample processing method for rapid detection of tuberculosis in the stool of pediatric patients using the Xpert MTB/RIF assay’, PloS one. Public Library of Science, 11(3), p. e0151980.
Blakemore, R. et al. (2010) ‘Evaluation of the analytical performance of the Xpert MTB/RIF assay’, Journal of clinical microbiology. Am Soc Microbiol, 48(7), pp. 2495–2501.
Boehme, C. C. et al. (2011) ‘Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study’, The lancet. Elsevier, 377(9776), pp. 1495–1505.
Burhan, E. et al. (2013) ‘Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients’, Antimicrobial agents and chemotherapy. Am Soc Microbiol, 57(8), pp. 3614–3619.
Creswell, J. et al. (2014) ‘Results from early programmatic implementation of Xpert MTB/RIF testing in nine countries’, BMC infectious diseases. BioMed Central, 14(1), p. 2.
Gandhi, N. R. et al. (2010) ‘Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis’, The Lancet. Elsevier, 375(9728), pp. 1830–1843.
Joshi, B. et al. (2018) ‘The implementation of Xpert MTB/RIF assay for diagnosis of tuberculosis in Nepal: A mixed-methods analysis’, PloS one. Public Library of Science, 13(8), p. e0201731.
Khan, A. S. et al. (2018) ‘Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan’, brazilian journal of microbiology. SciELO Brasil, 49(4), pp. 909–913.
KNCV Indonesia (2017) Petunjuk Teknis Pemeriksaan TB dengan TCM.
Moussa, H. S., Bayoumi, F. S. and Ali, A. M. (2016) ‘Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis’, Saudi medical journal. Saudi Medical Journal, 37(10), p. 1076.
Nathanson, E. et al. (2010) ‘MDR tuberculosis—critical steps for prevention and control’, New England Journal of Medicine. Mass Medical Soc, 363(11), pp. 1050–1058.
Parsons, L. M. et al. (2011) ‘Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities’, Clinical microbiology reviews. Am Soc Microbiol, 24(2), pp. 314–350.
Piatek, A. S. et al. (2013) ‘GeneXpert for TB diagnosis: planned and purposeful implementation’, Global Health, Science and Practice, 1(1), p. 18. doi: 10.9745/ghsp-d-12-00004.
Praveen, J. V et al. (2014) ‘Gene Xpert MTB/RIF-a novel diagnostic tool for rapid and specific detection of mycobacterium tuberculosis in pulmonary samples’, J Evol Med Dent Sci, 3(32), pp. 8756–8760.
Tortoli, E. et al. (2012) ‘Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis’, European Respiratory Journal. Eur Respiratory Soc, 40(2), pp. 442–447.
WHO (2013) Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children: expert group meeting report: 2013. World Health Organization.
WHO (2014) Global Tuberculosis Report 2014.
Zmak, L., Jankovic, M. and Jankovic, V. K. (2013) ‘Evaluation of Xpert MTB/RIF assay for rapid molecular diagnosis of tuberculosis in a two-year period in Croatia’, International journal of mycobacteriology. Elsevier, 2(3), pp. 179–182.
Zumla, A. et al. (2015) ‘The WHO 2014 global tuberculosis report—further to go’, The Lancet Global Health. Elsevier, 3(1), pp. e10–e12.
Published
2020-02-14
How to Cite
Novianti, N., Simarmata, O. and Lolong, D. (2020) “PEMANFAATAN TES CEPAT MOLEKULER (TCM) GENEXPERT SEBAGAI ALAT DIAGNOSTIK TB PARU DI RSUD WANGAYA KOTA DENPASAR”, JURNAL EKOLOGI KESEHATAN, 18(3), pp. 135-148. doi: 10.22435/jek.v3i18.2399.